Company overview
Sino Biological is an internationally recognized reagent supplier and contract research organization specializing in recombinant protein production and antibody development. The company offers over 6,000 recombinant proteins and 13,000 antibodies, produced using its proprietary mammalian cell-based expression system for high-efficiency antigen and antibody manufacturing. Headquartered in Beijing with subsidiaries in the United States and Europe, its products support virology, infectious disease research, and applications like SARS-CoV-2 diagnostics with FDA EUA approvals.
Sino Biological Inc is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, CRO & Clinical Services partner serving United States & Americas. Core focus areas include recombinant proteins, monoclonal antibodies, antigen production, cro services, sars-cov-2 reagents.
Industry categories: Life Science Reagents, CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.sinobiological.com
- Categories
- Life Science Reagents, CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- recombinant proteins, monoclonal antibodies, antigen production, cro services, sars-cov-2 reagents
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What are Sino Biological's core capabilities in recombinant proteins and antibodies?
- Sino Biological specializes in recombinant protein production and antibody development using a proprietary mammalian cell-based expression system, offering 6,000+ recombinant proteins and 13,000+ antibodies independently developed and produced.
- What regulatory approvals do Sino Biological's products have?
- Many of Sino Biological's SARS-CoV-2 antibodies and antigens have received Emergency Use Authorization (EUA) from the FDA for use in rapid antigen and antibody tests.
- In which geographies does Sino Biological operate?
- Headquartered in Beijing, China, Sino Biological has subsidiaries in the United States and Europe/Germany, with products available in more than 90 countries worldwide.
Related editorial coverage
- The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities in 2024
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
